Human clinical trials could begin as early as next year
A team of researchers at the University of Georgia’s Regenerative Bioscience Center and ArunA Biomedical, a UGA startup company, have developed a new treatment for stroke that reduces brain damage and accelerates the brain’s natural healing tendencies in animal models. They published their findings in the journal Translational Stroke Research.
The research team led by UGA professor Steven Stice and Nasrul Hoda of Augusta University created a treatment called AB126 using extracellular vesicles (EV), fluid-filled structures known as exosomes, which are generated from human neural stem cells.
Fully able to cloak itself within the bloodstream, this type of regenerative EV therapy appears to be the most promising in overcoming the limitations of many cell therapies—with the ability for exosomes to carry and deliver multiple doses—as well as the ability to store and administer treatment. Small in size, the tiny tubular shape of an exosome allows EV therapy to cross barriers that cells cannot.
“This is truly exciting evidence, because exosomes provide a stealth-like characteristic, invisible even to the body’s own defenses,” said Stice, Georgia Research Alliance Eminent Scholar and D.W. Brooks Distinguished Professor in the College of Agricultural and Environmental Sciences. “When packaged with therapeutics, these treatments can actually change cell progression and improve functional recovery.”
Following the administration of AB126, the researchers used MRI scans to measure brain atrophy rates in preclinical, age-matched stroke models, which showed an approximately 35 percent decrease in the size of injury and 50 percent reduction in brain tissue loss—something not observed acutely in previous studies of exosome treatment for stroke.
Outside of rodents, the results were replicated by Franklin West, associate professor of animal and dairy science, and fellow RBC members using a porcine model of stroke—the only one of its kind in the U.S.
Based on these pre-clinical results, ArunA Biomedical plans to begin human studies in 2019, said Stice, who is also chief scientific officer of ArunA Biomedical.
“Until now, we had very little evidence specific to neural exosome treatment and the ability to improve motor function,” said Stice. “Just days after stroke, we saw better mobility, improved balance and measurable behavioral benefits in treated animal models.”
Named as part of the ‘stroke belt’ region, Georgia continues to exceed the national average in stroke deaths, which is the third leading cause of death in the U.S., with more than 140,000 Americans dying each year, according to the Centers for Disease Control and Prevention.
ArunA recently unveiled advances to the company’s proprietary neural cell platform for the production of exosome manufacturing. Today, ArunA’s manufacturing process positions the company to produce AB126 exosomes at a scale to meet early clinical demand. The company has plans to expand this initiative beyond stroke for preclinical studies in epilepsy, traumatic brain and spinal cord injuries later this year.
The Latest on: Stroke treatment
- 8th International Congress on Stroke and Brain Hemorrhage on September 19, 2018 at 3:07 am
Brochure link: https://stroke.neurologyconference.com/europe/conference-brochure.php Conference topics: https://stroke.neurologyconference.com/europe/call-for-abstracts.php Submit your abstract at : h... […]
- UCalgary study could help physicians make better treatment decisions for stroke on September 18, 2018 at 10:20 pm
More than 80 percent of strokes are caused when a blood vessel to the brain becomes blocked, called an ischemic stroke. The right treatment at the right time can make a critical difference in a patien... […]
- Lawsuit says WMC negligent in stroke patient's treatment on September 18, 2018 at 9:44 pm
WINCHESTER — Winchester Medical Center touts its Advanced Primary Stroke Center’s quick responses. “The rapid, coordinated efforts of our team of physicians, nurses and technicians quickly identify pa... […]
- Stroke patients denied thrombectomy treatment, says Professor Keith Muir on September 17, 2018 at 5:21 pm
Stroke patients face a poorer chance of recovery because a life-changing treatment is not available in Scotland, a leading neurologist has warned. Keith Muir, who led UK trials of the procedure, descr... […]
- Critical differences in clots that cause a stroke on September 13, 2018 at 1:08 pm
There are two main treatments for stroke caused by a clot in a blood vessel in the brain. Scientists have discovered that clots have different compositions and depending on where they are located in t... […]
- Acute Ischemic Stroke Diagnosis and Treatment Market Is Expected to Surpass USD 1,869.7 Million by 2020 on September 12, 2018 at 8:49 pm
Albany, NY -- (SBWIRE) -- 09/12/2018 -- Acute ischemic stroke can be defined as loss of function in certain parts of brain due to lack or disturbance in the blood supply to the brain. This is usually ... […]
- Sleep Apnea Treatment Can Improve Neurological, Functional Recovery in Stroke Patients on September 12, 2018 at 2:12 am
Treating sleep apnea can significantly improve neurological and functional recovery in stroke patients, reports a new study. The findings of the study are published in the Journal of the American Hear... […]
- ReNeuron pushed back stroke treatment study timeline to 2020 on September 12, 2018 at 1:39 am
StockMarketWire.com - Cell-based therapeutics developer ReNeuron Group said it expected data from a study into a therapy for stroke disability to be released later than planned. Results were now antic... […]
- Kessler Foundation receives grant to study outcomes of new stroke treatment on September 10, 2018 at 2:19 pm
Kessler Foundation has been awarded a $50,000 grant by the Charles and Ann Serraino Foundation, Inc. The two-year grant will advance the Foundation's practice-based stroke rehabilitation research to a... […]
- Clinical trial to examine whether sleep apnea treatment prevents recurrent stroke, improves recovery on September 5, 2018 at 11:48 am
Recovery after a stroke is often challenging, and patients are also at heightened risk of another stroke. Now, with the launch of a new clinical trial, stroke survivors across the country will have th... […]
via Google News and Bing News